Use of Acetyl Salicylic Acid and Terbutalin in Assisted Reproductive Techniques (ART)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00518141 |
Recruitment Status
:
Completed
First Posted
: August 20, 2007
Last Update Posted
: July 21, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Reproductive Techniques, Assisted | Drug: Acetyl Salicylic Acid and Terbutalin | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 300 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Use of Acetylsalicylic Acid and Terbutalin in ART |
Study Start Date : | March 2006 |
Actual Primary Completion Date : | May 2009 |
Actual Study Completion Date : | May 2009 |
Arm | Intervention/treatment |
---|---|
Experimental: 1
FER
|
Drug: Acetyl Salicylic Acid and Terbutalin
ASA 75 mg, Terbutalin 5mg
|
No Intervention: 2
FER
|
|
Experimental: 3
SET
|
Drug: Acetyl Salicylic Acid and Terbutalin
ASA 75 mg, Terbutalin 5mg
|
No Intervention: 4
SET
|
|
Experimental: 5
DET
|
Drug: Acetyl Salicylic Acid and Terbutalin
ASA 75 mg, Terbutalin 5mg
|
No Intervention: 6
DET
|
- Pregnancy [ Time Frame: 7 weeks ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 39 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Infertile women below 39 years of age
Exclusion Criteria:
- Women who may react allergically to the drugs administered
- Women with hyperthyroid or IDDM
- Women who do not want to participate in the study
- Women who are unable to give informed, written consent.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00518141
Norway | |
STHF, Kvinneklinikken, Fertilitetsklinikken Sor | |
Porsgrunn, Telemark, Norway, 3901 |
Principal Investigator: | Jarl A Kahn, Dr. med | STHF, Kvinneklinikken, Fertilitetsklinikken Sor |
Responsible Party: | Jarl Kahn, Fertilitetsklinikken Sør |
ClinicalTrials.gov Identifier: | NCT00518141 History of Changes |
Other Study ID Numbers: |
S-06085 (REK) |
First Posted: | August 20, 2007 Key Record Dates |
Last Update Posted: | July 21, 2011 |
Last Verified: | July 2011 |
Additional relevant MeSH terms:
Salicylic Acid Salicylates Aspirin Terbutaline Anti-Infective Agents Antifungal Agents Keratolytic Agents Dermatologic Agents Anti-Inflammatory Agents, Non-Steroidal Analgesics, Non-Narcotic Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anti-Inflammatory Agents |
Antirheumatic Agents Cyclooxygenase Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Fibrinolytic Agents Fibrin Modulating Agents Platelet Aggregation Inhibitors Antipyretics Bronchodilator Agents Autonomic Agents Anti-Asthmatic Agents Respiratory System Agents Sympathomimetics Tocolytic Agents Reproductive Control Agents |